TEV-48125

· Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for TEV-48125, covering 2018-11-08 to 2021-10-28. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine Patients [Phase 3]